| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Assessment of immunologic response and recurrence patterns among patients with clinical recurrence after vaccination with a preventive HER2/neu peptide vaccine: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02
|
Amin, Asna
|
|
2008
|
57 |
12 |
p. 1817-1825
|
artikel
|
| 2 |
Assessment of immunologic response and recurrence patterns among patients with clinical recurrence after vaccination with a preventive HER2/neu peptide vaccine: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02
|
Amin, Asna
|
|
|
57 |
12 |
p. 1817-1825
|
artikel
|
| 3 |
Dendritic cell-based vaccines suppress metastatic liver tumor via activation of local innate and acquired immunity
|
Yamaguchi, Shinjiro
|
|
2008
|
57 |
12 |
p. 1861-1869
|
artikel
|
| 4 |
Differential responses of cellular immunity in patients undergoing neoadjuvant therapy followed by surgery for carcinoma of the oesophagus
|
Westerterp, Marinke
|
|
2008
|
57 |
12 |
p. 1837-1847
|
artikel
|
| 5 |
HLA typing demands for peptide-based anti-cancer vaccine
|
Nagorsen, Dirk
|
|
2008
|
57 |
12 |
p. 1903-1910
|
artikel
|
| 6 |
Immunization with a GM3 ganglioside nanoparticulated vaccine confers an effector CD8+ T cells-mediated protection against melanoma B16 challenge
|
Mazorra, Zaima
|
|
2008
|
57 |
12 |
p. 1771-1780
|
artikel
|
| 7 |
Immunomodulatory drugs Revlimid® (lenalidomide) and CC-4047 induce apoptosis of both hematological and solid tumor cells through NK cell activation
|
Zhu, Dan
|
|
2008
|
57 |
12 |
p. 1849-1859
|
artikel
|
| 8 |
Intratumoral immunocytokine treatment results in enhanced antitumor effects
|
Johnson, Erik E.
|
|
2008
|
57 |
12 |
p. 1891-1902
|
artikel
|
| 9 |
Kinetics of anti-carcinoembryonic antigen antibody internalization: effects of affinity, bivalency, and stability
|
Schmidt, Michael M.
|
|
2008
|
57 |
12 |
p. 1879-1890
|
artikel
|
| 10 |
Progression of intracranial glioma disrupts thymic homeostasis and induces T-cell apoptosis in vivo
|
Andaloussi, Abdeljabar El
|
|
2008
|
57 |
12 |
p. 1807-1816
|
artikel
|
| 11 |
RhoC a new target for therapeutic vaccination against metastatic cancer
|
Wenandy, Lynn
|
|
2008
|
57 |
12 |
p. 1871-1878
|
artikel
|
| 12 |
Selective accumulation of differentiated FOXP3+ CD4+ T cells in metastatic tumor lesions from melanoma patients compared to peripheral blood
|
Jandus, Camilla
|
|
2008
|
57 |
12 |
p. 1795-1805
|
artikel
|
| 13 |
Targeting activity of a TCR/IL-2 fusion protein against established tumors
|
Wen, Jinghai
|
|
2008
|
57 |
12 |
p. 1781-1794
|
artikel
|
| 14 |
Therapeutic effect of a T helper cell supported CTL response induced by a survivin peptide vaccine against murine cerebral glioma
|
Ciesielski, Michael J.
|
|
2008
|
57 |
12 |
p. 1827-1835
|
artikel
|
| 15 |
Therapeutic efficacy of antitumor dendritic cell vaccinations correlates with persistent Th1 responses, high intratumor CD8+ T cell recruitment and low relative regulatory T cell infiltration
|
Driessens, Gregory
|
|
2008
|
57 |
12 |
p. 1745-1756
|
artikel
|
| 16 |
Virulizin® induces production of IL-17E to enhance antitumor activity by recruitment of eosinophils into tumors
|
Benatar, Tania
|
|
2008
|
57 |
12 |
p. 1757-1769
|
artikel
|
Tijdschrift beschrijving